Lisata Therapeutics CEO Dr David Mazzo on global product license deal with Catalent

By Proactive Investors / October 09, 2025 / www.youtube.com / Article Link


Lisata Therapeutics Inc (NASDAQ:LSTA) CEO Dr David Mazzo talked with Proactive's Stephen Gunnion about the company's new ...

Recent News

A shift to the later stages of gold and silver bull markets
October 27, 2025 / www.canadianminingreport.com

Gold stocks plunge on metal drop
October 27, 2025 / www.canadianminingreport.com

Gold stocks still up after pullback late in the week
October 20, 2025 / www.canadianminingreport.com

US regional bank slump goes global, driving market into gold
October 20, 2025 / www.canadianminingreport.com

Gold stocks weaker but outperform slump in other sectors
October 13, 2025 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok